MedicaidJune 27, 2023
IV Iron Medical Step Therapy Notice
Effective for dates of service on and after August 1, 2023, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our existing specialty pharmacy medical step therapy review process. Step therapy review will apply upon prior authorization initiation or renewal in addition to the current medical necessity review of all drugs noted below.
The list of Clinical Criteria is publicly available on our provider website. Visit the Clinical Criteria website to search for specific Clinical Criteria.
Clinical Criteria | Status | Drug | HCPCS or CPT® code(s) |
Non-preferred | Infed (iron dextran) | J1750 | |
Non-preferred | Injectafer (ferric carboxymaltose) | J1439 | |
Non-preferred | Monoferric (ferric derisomaltose) | J1437 | |
Preferred | * Feraheme (ferumoxytol) | Q0138 | |
Preferred | Ferrlecit (sodium ferric gluconate/sucrose complex) | J2916 | |
Preferred | Venofer (iron sucrose) | J1756 |
* Feraheme (ferumoxytol) will change to preferred for both brand and generic.
Availity Essentials* Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to availity.com and select the appropriate payer space tile from the drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat.
For additional support, visit the Contact Us section at the bottom of our provider website for the appropriate contact.
* Availity, LLC is an independent company providing administrative support services on behalf of the health plan.
KYBCBS-CD-018622-23-CPN18331
PUBLICATIONS: August 2023 Provider Newsletter
To view this article online:
Visit https://providernews.anthem.com/kentucky/articles/iv-iron-medical-step-therapy-notice-1-14203
Or scan this QR code with your phone